Acadia Healthcare Company (ACHC) Current Deferred Revenue (2016 - 2025)
Acadia Healthcare Company (ACHC) has disclosed Current Deferred Revenue for 11 consecutive years, with $2.8 million as the latest value for Q4 2025.
- On a quarterly basis, Current Deferred Revenue rose 66.37% to $2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.8 million, a 66.37% increase, with the full-year FY2025 number at $2.8 million, up 66.37% from a year prior.
- Current Deferred Revenue was $2.8 million for Q4 2025 at Acadia Healthcare Company, up from $1.7 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $49.2 million in Q1 2021 to a low of $1.7 million in Q4 2024.
- A 5-year average of $14.9 million and a median of $5.9 million in 2022 define the central range for Current Deferred Revenue.
- Peak YoY movement for Current Deferred Revenue: crashed 80.62% in 2023, then surged 66.37% in 2025.
- Acadia Healthcare Company's Current Deferred Revenue stood at $30.4 million in 2021, then plummeted by 78.09% to $6.7 million in 2022, then plummeted by 67.46% to $2.2 million in 2023, then dropped by 22.12% to $1.7 million in 2024, then skyrocketed by 66.37% to $2.8 million in 2025.
- Per Business Quant, the three most recent readings for ACHC's Current Deferred Revenue are $2.8 million (Q4 2025), $1.7 million (Q4 2024), and $1.7 million (Q3 2024).